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Abstract: The toxicity of lead and the solvents utilized during the 
synthesis of hybrid halide perovskite films are potential obstacles for 
widespread applications of solar cell technology based on these 
materials. Alternatives such as those based on lead-free Sn-based 
devices often suffer from poor film morphologies, thus precluding 
competitive device efficiencies. Here, we demonstrate a new one-step 
route deploying mixtures of the less hazardous methanol and 1,4-
dioxane for preparing high-quality methylammonium tin iodide films. 
We propose that the fast evaporation of these solvents is a key factor 
for film formation and show that the solvent ratio is essential to obtain 
phase pure, high-quality films. This leads to devices which outperform 
those prepared by conventional routes, likely due to a decreased 
defect density as confirmed with time-resolved photoluminescence 
measurements. Our results provide a further step towards non-
hazardous synthesis routes for Sn-based optoelectronic devices. 
Introduction 
The constant increase of global energy consumption 
accompanied by the decline of fossil fuels generates a strong 
demand for new, sustainable energy sources.[1] In the past few 
years, organic-inorganic lead halide perovskites have emerged as 
highly efficient and inexpensive absorber materials for solar 
cells.[2,3] The simple processability and high power conversion 
efficiencies of over 20 % for state-of-the-art devices, assembled 
with methylammonium lead iodide (MAPbI3), make these 
materials interesting candidates for large-scale applications.[4–6] 
Due to the solubility of the lead salts in water, the toxicity of high-
performing hybrid halide perovskites can be considered as a 
major barrier for commercializing this technology. Therefore, a 
great deal of effort has been undertaken to develop lead-free 
perovskite-related compounds based on Ge2+, Sn2+, Bi3+, Sb3+ or 
Cu2+ for photovoltaic applications.[7–11] Sn-based compounds with 
the general formula ASnX3, where A can be Cs, methylammonium 
(MA) or formamidinium (FA) and X can be I, Br, Cl or F, are the 
most promising alternatives to lead-based materials, with 
reported power conversion efficiencies (PCE) of  6 % for devices 
based on methylammonium tin iodide (MASnI3) films.[12,13] The 
lower efficiencies compared to lead-based materials are generally 
assigned to Sn4+ self-doping due to the facile oxidation of Sn2+ 
under ambient conditions.[13–17] 
Further toxicity concerns arise from the harmful solvents utilized 
during the preparation of the perovskite films. The most common 
solvent, N,N-dimethylformamide (DMF), is known to be strongly 
hepatotoxic, even at relatively low concentrations, and the 
European Union has classified it as toxic to reproduction.[18–21] 
Furthermore, it can easily be taken up by dermal absorption, 
which is troubling since the dwell time of DMF in the body is much 
longer for percutaneous uptake than for pulmonary ingestion.[22] 
The second widespread solvent, dimethylsulfoxide (DMSO), 
although not acutely toxic, can induce bradycardia, respiratory 
problems, and alterations in blood pressure.[23,24] Furthermore, it 
potentially alters the chemical structure of cell membranes and 
thus their functional properties.[25] However, the most critical 
property of DMSO is that it can serve as an efficient carrier for 
other agents by enhancing the penetration through skin tissue, 
which is particularly critical for toxic substances like soluble lead 
compounds.[26]  
With the prospect of possible commercialization of solution-
processable solar cells, the development of less toxic film 
formation routes is an important issue to minimize the health risks 
during the film preparation. This must be balanced with the 
formation of homogenous films which uniformly cover the 
substrate. Considering Pb-based solar cells, the development of 
advanced film formation methods has led to homogeneous, 
smooth and pinhole-free perovskite films and has been the driving 
factor behind the great leaps in device efficiency.[27] Accordingly, 
the synthesis of high-quality MASnI3 films can be considered as a 
key task to enable the system for high-efficiency photovoltaic 
applications.  
MASnI3 forms very rough and inhomogeneous films with micron-
sized pinholes when employing common deposition methods 
based on DMF due to the much faster crystallization process as 
compared to MAPbI3,. This, in turn, results in severely shunted 
photovoltaic devices. [12,13,15,28,29] In order to resolve these issues, 
Hao et al. developed a deposition route based on a (DMSO)-SnI2 
intermediate phase which improved the surface coverage by slow 
crystallization of the perovskite.[30] An alternative route was 
developed by Yokoyama et al. who adapted the well-known 
vapour-assisted solution process for the preparation of 
homogeneous but not crack-free MASnI3 films.[31,32]
 Recently, 
Long et al. have developed a synthetic route for high-quality 
FASnI3 films based on antisolvent dripping.[33] However, all three 
methods still rely 
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on the hazardous DMF or DMSO solvents to deposit the metal 
halide layer. Previous studies on lead based hybrid perovskites 
showed that the hazardous solvents can be replaced by water to 
deposit the metal halide layer.[34,35] However, due to the sensitivity 
of the Sn2+ ion to oxygen and moisture this approach cannot be 
transferred to the lead-free compound.[13]  
Here, we demonstrate a new one-step synthesis route for the 
preparation of high-quality, lead-free MASnI3 films for photovoltaic 
applications based on less hazardous solvents (methanol 
(MeOH) and 1,4-dioxane (Dioxane)). Our route provides high 
quality films which outperform conventional one-step synthesis 
routes based on DMF and DMSO in photovoltaic devices. Our 
results represent a further step towards efficient lead-free 
perovskite based solar cells manufactured under non-dangerous 
conditions. 
Results and Discussion 
Our films were prepared on a 250 nm thick titanium dioxide (TiO2) 
scaffold via a one-step spin-coating process from precursors 
dissolved in a MeOH: Dioxane mixture. As a reference, we also 
prepared MASnI3 films utilizing the most common conventional 
one-step routes according to literature.[12,30] 
When employing our newly developed MeOH/Dioxane route, the 
perovskite film forms within a few seconds after application of the 
solution, as depicted schematically in Figure 1. Since MeOH and 
Dioxane feature rather high vapour pressures of 130 hPa[36] and 
37 hPa[37] at 20 °C, rapid solvent evaporation is expected. 
Accordingly, we propose that the fast supersaturation of the 
perovskite solution leads to the formation of a large number of 
small nuclei, resulting in smooth and homogeneous MASnI3 films 
after complete solvent evaporation. Due to the faster 
crystallization of MASnI3 compared to MAPbI3, the rapid solvent 
Figure 1. Schematic of the MeOH/Dioxane route. For simplification, only a few crystallites are depicted. The arrow underneath indicates the time range within 
which film formation usually occurs. 
Figure 2. SEM images of MASnI3 films on TiO2 scaffold substrate: (a) DMF solution, (b) DMSO solution, (c) MeOH/Dioxane. Panels d – f represent SEM images 
of films a – c at higher magnifications, respectively. 
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evaporation is essential to inhibit the growth of large, pointy 
crystals which protrude from the substrate and lead to substantial 
pinholes in the hole transporting layer (HTL).  
Scanning electron microscopy (SEM) images revealed large 
differences in the morphology of MASnI3 films made from the 
different solvents. As shown in Figure 2a, films prepared from a 
DMF solution are inhomogeneous, featuring a pattern of large 
MASnI3 grains with low surface coverage. Figure 2b shows the 
SEM image of a MASnI3 film made from a DMSO solution 
featuring enhanced homogeneity with less prominent patterns 
compared to films prepared from DMF solution. However, films 
made by our newly developed MeOH/Dioxane method (Figure 2c) 
exhibit films that fully cover the substrate with no visible pinholes 
or large protruding crystals, similar to those prepared by Long et 
al. via their developed antisolvent dripping route.[33]  
Higher magnifications of the depicted films (Figure 2d-f) reveal 
striking morphology differences. In the films manufactured from 
the conventional solvents DMF and DMSO (Figure 2d,e) the 
porous TiO2 scaffold is directly visible. In contrast, the film 
prepared from MeOH/Dioxane features a dense, homogeneous 
MASnI3 capping layer exhibiting many relatively small crystallites, 
which supports our proposed film formation mechanism. In 
contrast with 2-step deposition methods that result in small cuboid 
crystals, the MeOH:Dioxane route yields a smooth capping layer 
consisting of non-regular-shaped crystals, similar to those from 
Yokoyama et al.[32] This dense capping layer is an important 
feature of high-efficiency perovskite solar cells,[38] as it prevents 
the direct contact of the HTL with the electron-transporting TiO2.  
The key enabler of the developed route based on less hazardous 
solvents is possible due to the higher solubility of SnI2 in alcohols 
compared to PbI2.[29] However, simply employing MeOH, which 
showed the highest solubility for MASnI3 during our studies, leads 
to rather low concentrations of  0.1 M. The addition of a miscible 
co-solvent that can complex with Sn(II) in the form of Dioxane,  
greatly increases the saturation  concentration of the precursor 
mixture up to ~0.3 M.[39,40] 
To gain more knowledge about the influence of Dioxane during 
the film formation, we prepared perovskite solutions with 25 % 
(v/v), 50 % (v/v) or 75 % (v/v) of Dioxane at a given MASnI3 
concentration of 0.3 M. We observed a decreasing solubility of the 
perovskite with higher concentrations of Dioxane, eventually 
leading to the formation of a black MASnI3 precipitate at the 
highest concentration (see Figure 3a), confirmed by PXRD 
measurements (see Figure 3b). 
Since highly polar solvents are commonly used to dissolve 
MASnI3, it is likely that the reduction of the solubility is due to the 
small dipole moment of Dioxane.[41] This, in turn, suggests that the 
enhanced solubility of MASnI3 in the MeOH/Dioxane solvent 
mixture at low Dioxane concentrations is not caused by the good 
solubility of the perovskite in Dioxane, but rather by the 
coordination of the solvent to Sn(II).[38,39] Since stable Sn(II)-
(Dioxane) complexes are known for SnCl2[40] and SnBr2[39], we 
propose an inhibited reaction of MAI with SnI2 to MASnI3 in 
solution by the formation of Sn(II)-(Dioxane) adducts, resulting in 
an increased solubility of MASnI3 in the utilized solvent mixture. 
The perovskite films form within a few seconds because of the 
high vapour pressure of the utilized solvents, and therefore a 
direct proof for the proposed Sn(II)-(Dioxane) adduct by 
commonly used FTIR measurements is not possible.  
In order to address this, we performed PXRD measurements to 
obtain an indirect indication of the adduct, as shown in Figure 3b. 
Here, we observe additional reflections at the highest Dioxane 
concentration, which can be assigned to SnI2. This is likely 
caused by the stabilization of the Sn(II)-(Dioxane) adduct at high 
Dioxane concentrations, which prevents its complete reaction 
with MAI to MASnI3. Accordingly, we found an optimum in film 
quality and no phase segregation for 25 % (v/v) Dioxane. Thus, 
only the MASnI3 film properties made from solutions containing 
25 % (v/v) Dioxane are discussed in the following. 
Figure 3. (a) Images of solutions prepared with 25 % (v/v), 50 % (v/v) or 75 % 
(v/v) Dioxane. The black precipitate can clearly be seen for the highest 
Dioxane concentration. (b) PXRD pattern of MASnI3 films prepared from 
precursor solutions containing the three different Dioxane concentrations. 
The simulated patterns for MASnI3 (black) and SnI2 (red) are also given. 
Additionally, the PXRD pattern of the precipitate obtained from the solution 
with the highest Dioxane concentration is depicted (green). 
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We investigated the influence of the three different film formation 
methods (Sn-perovskite films prepared either from DMF, DMSO 
or MeOH/Dioxane solutions) on the photovoltaic properties by 
incorporating the resulting films in devices with the typical layer 
assembly of fluorine doped tin oxide (FTO)/compact-
TiO2/mesoporous-TiO2/perovskite/HTL/Au contact.[31] A 
schematic of the solar cells and a cross-sectional image of a 
functional MeOH/Dioxane-derived device utilizing 2,2’,7,7’-
tetrakis-(N,N-di-pmethoxyphenylamine)9,9’-spirobifluoren (spiro-
OMeTAD) as HTL are given in Figure 4a and 4b. The MASnI3 
capping layer on top the mesoporous-TiO2 can clearly be seen, 
which is a a feature of high efficiency devices as it prevents 
shunting paths in devices. [13,32] 
In order to further improve the device performance, we partially 
substituted iodide by bromide, which leads to a slightly smaller 
unit cell due to the smaller bromide without changing the 
tetragonal structure of the perovskite (see Figure S4). Hao et al. 
showed that bromide has a beneficial effect on the device 
performance, mainly due to the reduction of the series resistance 
RS and the increase of the VOC.[12] Additionally, they showed that 
bromide enhances the lifetime of the photoexcited species by 
destabilizing Sn2+/Sn4+ defects leading to an enhanced charge 
collection efficiency resulting in a higher JSC.[42] In our case, we 
obtained the best performing devices from a perovskite 
composition of MASnBr0.5I2.5. 
The current-voltage (J-V) curves of the best performing devices 
out of 36 individual solar cells per synthesis route are displayed 
in Figure 4c. We obtained consistently very poor performance for 
devices assembled with MASnBr0.5I2.5 films prepared from DMF 
or DMSO solutions. In this case, the J-V curves show severely 
shunted behavior and PCEs of 0.04 % and 0.01 %,with short-
circuit currents (JSC) of 8.84 mA/cm² and 4.67 mA/cm² and open-
circuit voltages (VOC) of 0.02 V and 0.01 V for the best devices, 
which is in good agreement with reported values by Hao et al. and 
Takamichi et al..[30, 32] In contrast, the solar cells obtained via the 
MeOH/Dioxane route exhibit an enhanced performance with the 
highest PCE of 1.05 % with a JSC of 15.44 mA/cm², VOC of 0.18 V 
and a FF of 38 %. We note that devices based on films prepared 
on the MeOH/Dioxane route show prominent hysteresis similar to 
that observed for photovoltaics based on lead halide perovskite, 
see Figure S6.[43–46] 
 
Figure 4. (a) Schematic of an assembled solar cell. (b) Cross-sectional SEM image of a functional device assembled with a MeOH/Dioxane MASnI3 film. (c) Current-
voltage characteristic showing the dependence of device performance on the deposition route. Hollow symbols refer to dark current traces (d) Time-resolved 
photoluminescence measurements of MASnBr0.5I2.5 films made from DMF, DMSO and MeOH/Dioxane solution. 
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While low, the performance of the MeOH/Dioxane based devices 
is still in the range of reported results on tin halide perovskite-
based solar cells by Yokoyama et al. and Long et al. showing a 
best PCE of 1.86 % and 0.11 %, respectively.[32,33] This is likely a 
result of the encapsulation protocol which requires a long 12h 
curing period in a nitrogen atmosphere which lowers the device 
performance.[12] We note that our champion device exhibits an 
almost ten times higher PCE compared to that prepared by Long 
et al. while both devices feature very similar morphologies, 
pointing to the high sensitivity of tin halide based perovskite to the 
synthesis conditions.[33] 
 
The VOC value for devices featuring tin-based perovskites is 
heavily impacted by first order recombination due to intrinsic 
defects, such as Sn vacancies, which depend on the Sn4+ doping 
level.[13,28] Hence, it is essential to keep the Sn4+ doping level as 
low as possible. Previous studies revealed that commercially 
available SnI2 already contains a significant amount of Sn4+ 
similar to the precursor purchased for our studies.[12] Additionally, 
it has been shown that a voltage loss is also incurred due to the 
misalignment of the conduction band (CB) of the Sn-perovskite 
and the CB of TiO2.[30,32] 
In an effort to reduce the defect density, we purified the starting 
material according to the protocol established by Hao et al.[30,32] 
However, in our lab, we found no enhancement in the 
performance, see Figure S7. Another approach to reducing the 
defect density is the use of an excess of SnF2 as reducing agent. 
Due to the very low solubility of SnF2 in our solvent mixture, we 
could not observe an effect on device performance. However, 
since the highest reported PCE values for MASnI3 based devices 
were obtained without the addition of SnF2, we strongly believe 
that the new MeOH/Dioxane route holds promise for better-
performing devices. 
Further information about defects in the perovskite materials can 
be gained through time-resolved photoluminescence (PL) 
measurements.[13] Previous studies on Pb-based devices 
revealed that a long lifetime is associated with the presence of 
long-lived charge carriers, resulting in an increased charge 
extraction efficiency.[47,48].Similar studies on MASnI3 yielded 
lifetimes of the photoexcited species of about 200 ps, being much 
shorter than for the lead-based counterpart[13,47,48] Here, we 
performed time-correlated single-photon counting (TCSPC) 
measurements on Sn-perovskite films prepared either from DMF, 
DMSO or MeOH/Dioxane solutions. All films show strong PL at 
around 840 nm (Figure S8), as expected. The corresponding PL 
decays are depicted in Figure 4d. All samples exhibit fast decays 
with the shortest lifetime values for perovskite films prepared from 
DMF solution (310 ps) and DMSO solution (260 ps), similar to 
previously reported values for MASnI3.[13].The short lifetimes in 
these systems are typically assigned to the fast electron-hole pair 
recombination at Sn2+/Sn4+ defect sites, most likely due to self-
doping of the Sn-perovskite[13,16,41,49].Surprisingly, the 
MASnBr0.5I2.5 film deposited from the MeOH/Dioxane route 
exhibits a significantly longer lifetime of the excited species of 
580 ps, indicating a lower defect density in the material. These 
TCSPC measurements provide a first indication that our newly 
developed MeOH/Dioxane route is suitable for preparing Sn-
perovskite films with competitive photophysical properties. 
Regarding toxicity concerns of the new MeOH/Dioxane route, 
both applied solvents represent less harmful alternatives to the 
commonly utilized solvents for perovskite film synthesis. Dioxane 
is a common solvent used in paints, varnishes, inks and dyes. 
Furthermore, it is a natural component in some food products, like 
tomatoes, shrimp and coffee. [50] Dioxane is, similar to DMSO, not 
classified as acutely toxic but animal experiments suggest a 
potentially carcinogenic effect, which could not be supported by 
studies on human workers exposed to occupational doses of 
Dioxane over decades.[50,51] Based on this, the International 
Agency for Research on Cancer (IARC) classified Dioxane as a 
2B carcinogen just as carbon black and TiO2, leading to the 
conclusion that Dioxane is not associated with cancer formation 
under common occupational conditions.[52,53]  
MeOH is a widespread chemical for industrial applications, 
occurring naturally in humans, animals and plants. Excessive 
uptake of MeOH can cause blindness and death but the lethal 
dose is about twice as high as for DMF.[54,55] For occupational 
exposure not only the toxicity is important but also, the ability of 
the solvents to enter the body by different pathways. The effect of 
the different uptake pathways like oral ingestion, percutaneous 
absorption or inhalation on the body are important factors to 
assess the overall hazardousness. In particular, dermal 
absorption and inhalation of the solvents are of special interest, 
since these are considered to be the most likely uptake routes 
under occupational conditions.[56]  
A comparison of the two solvents MeOH and Dioxane, utilized in 
our new synthesis route, with the commonly used solvents DMF 
and DMSO reveals that all solvents, except Dioxane, feature a 
high ability to penetrate through the skin, where DMSO exhibits, 
by far, the highest permeability rate among the mentioned 
solvents.[57–60] This high ability to penetrate through the skin tissue 
combined with their ability to act as an excellent carrier for a wide 
range of agents makes DMSO a much more critical solvent than 
Dioxane although both are not acutely toxic.[26] Furthermore, DMF 
and MeOH show very similar permeability rates, which means that 
both solvents have a similar ability to penetrate through the skin 
tissue.[57,58] Previous studies showed that dermal exposure to 
MeOH or DMF leads to increased concentrations of the particular 
chemical in the blood and urine of the experimental subjects.[57,58]  
Despite the very similar behaviour regarding dermal uptake, the 
degradation of the solvents in the body is very different. Chang et 
al. showed that dermal exposure to DMF of workers of a synthetic 
leather factory for several consecutive working days leads to a 
significant accumulation of the DMF body burden.[60] Although 
there is no comparable data available for MeOH, Battermann et 
al. revealed a clearance of MeOH in the body after dermal 
exposure of a few hours indicating the absence of MeOH 
accumulation in the body.[57] However, due to the high volatility of 
MeOH, the most probable uptake route is considered to be 
inhalation. Long-term studies on experimental subjects exposed 
to MeOH vapors for four consecutive days (8h/d) revealed no 
MeOH accumulation in the blood and urine of the experimental 
subjects at MeOH concentrations in the air slightly above the 
permissible exposure limit (PEL) of 260 mg/m³ stated by the 
National Institute for Occupational Safety and Health 
(NIOSH).[54,61] Accordingly, the World Health Organization (WHO) 
considers MeOH as non-hazardous under occupational 
conditions, maintaining the PEL.[62]  
In contrast, similar studies on DMF over a period of five 
consecutive days showed an accumulation of the toxic DMF 
metabolic product N-acetyl-S-(N-methylcarbamoyl)cysteine in the 
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blood and urine of the experimental subjects even at the PEL of 
30 mg/m3.[55,63] Furthermore, long-term exposure to DMF induces 
negative effects, like stomach pain, loss of appetite, nausea, 
headache and alcohol intolerance even at air concentrations 
below the PEL.[64,65] Accordingly, our new route based on MeOH 
and Dioxane can be regarded as a far less harmful synthesis 
route for the preparation of lead-free perovskite films. 
Conclusions 
In conclusion, we have demonstrated a new synthesis route for 
high-quality MASnI3 films employing less hazardous solvents in 
an effort to address toxicity concerns. This new approach is based 
on the higher solubility of Sn(II) salts in alcoholic solvents 
compared to the usual lead compounds, which allowed us to 
deposit films from a MeOH/Dioxane mixture. Here, we found that 
the addition of Dioxane greatly enhances the solubility of SnI2, 
essential to achieve films of several hundred nanometers in 
thickness, through the formation of Sn(II)-(Dioxane) adducts. Both 
MeOH and Dioxane feature high vapour pressures which, upon 
deposition and evaporation on the substrate, quickly lead to 
supersaturation of the precursor mixture and the formation of a 
large number of nuclei, leading to far smoother and homogeneous 
films than those prepared from conventional DMF or DMSO 
mixtures. Solar cells prepared with our new deposition route 
perform better than films prepared by conventional one-step 
routes, mainly due to the better film formation and fewer defects 
as indicated by time-resolved PL measurements. This opens a 
new avenue for more environmentally friendly and non-hazardous 
synthesis routes for perovskite-based solar cells. 
Experimental Section 
All chemicals were used as received without any further purification. All 
synthesis steps were conducted in a nitrogen-filled glove box to avoid 
oxidation of the Sn(II) compounds. 
Substrate preparation: Fluorine-doped tin oxide (FTO)-coated glass 
sheets (7 Ωsq-1, Pilkington, USA) were patterned by etching with zinc 
powder and 3 M HCl. They were subsequently cleaned with a 2% 
Hellmanex solution and rinsed with deionized water, ethanol, and acetone. 
Directly before applying the blocking layer, remaining organic residues 
were removed by an oxygen plasma treatment for 5 min. A compact 
titanium dioxide (TiO2) layer was deposited by spin-coating a sol-gel 
precursor solution at 2000 rpm for 45 s followed by subsequent annealing 
at 500 °C for 45 min. For the sol-gel solution a 27.2 mM (70 µL) solution of 
HCl in 2-propanol (5 mL) was added dropwise to a vigorously stirred 0.43 
mM (735 µL) solution of titanium isopropoxide (99.999%, Sigma–Aldrich) 
in 2-propanol (5 mL). Afterwards, a 250 nm thick, mesoporous TiO2 layer 
was applied by spin-coating 100 µL of a TiO2 nanoparticle paste (Dyesol 
DSL 18NR-T) diluted in absolute ethanol (1:3.5 weight ratio) onto the 
compact TiO2 layer at 2500 rpm for 30 s followed by subsequent annealing 
at 500 °C for 15 min.  
Perovskite film preparation 
Method 1: MeOH/Dioxane. The precursor solution was prepared by 
dissolving 111.6 mg SnI2 (99.999%, ultra dry, Alfa Aesar) in 1,4-dioxane 
(0.25 mL, Dioxane, anhydrous, 99.8 %, Sigma-Aldrich). In a second vial, 
either 48 mg of methylammonium iodide (MAI, Dyesol), for the pure iodide 
perovskite, or a mixture of 24 mg MAI and 17 mg methylammonium 
bromide (MABr, Dyesol), for the mixed halide perovskite, were dissolved 
in methanol (0.75 mL, MeOH, anhydrous, 99.8 %, Sigma-Aldrich). After 
complete dissolution of the organic precursor, the MeOH solution was 
added to the SnI2 solution to dissolve the remaining SnI2 completely. 
Subsequently, 100 µL of the precursor solution was spun onto the TiO2-
covered substrates at 3000 rpm for 15 s. The substrates were annealed at 
70 °C for 10 min to remove possible solvent residues directly after spin-
coating. 
Method 2: DMF. The perovskite solution was prepared by dissolving 372 
mg SnI2 and 159 mg MAI for the pure iodide compound or a mixture of 80 
mg MAI and 56 mg MABr, for the mixed halide perovskite, in N,N-
dimethylformamide (1 mL, DMF, anhydrous, 99.8 %, Sigma-Aldrich). After 
mixing, the solution was placed on a hotplate at 100 °C in order to fully 
dissolve the tin precursor. 100 µL of the precursor solution were spun at 
2000 rpm for 30 s onto a TiO2-covered substrate with subsequent 
annealing at 100 °C for 10 min.  
Method 3: DMSO. The procedure followed is the same as the previous 
procedure but using dimethylsulfoxide (DMSO, anhydrous, ≥99.9 %, 
Sigma-Aldrich) instead of DMF as the solvent. 100 µL of the precursor 
solution were spun at 4000 rpm for 30 s onto a TiO2-covered substrate with 
subsequent annealing at 100 °C for 10 min.  
Solar cell fabrication: After film formation, the films were covered with a 
hole transporting layer (HTL) of 2,2’,7,7’-tetrakis-(N,N-di-
pmethoxyphenylamine)9,9’-spirobifluorene (spiro-OMeTAD Borun 
Chemicals, 99.5% purity). The HTL solution was prepared by dissolving 
73 mg of spiro-OMeTAD in chlorobenzene (1 mL, 99.8%, Sigma–Aldrich). 
The solution was filtered and mixed with 2,5-lutidine (30 µL, 98+%, Alfa 
Aesar), and a 520 mg mL-1 bis(trifluoromethane)sulfonamide lithium salt 
(LiTFSI, 99.95%, Sigma–Aldrich) solution in acetonitrile (17.5 µL). This 
solution was spin-coated dynamically at 1500 rpm for 45 s. In a second 
step the sample rotation was accelerated to 2000 rpm for 5 s to allow the 
solvent to dry completely. Finally, the 40 nm thick gold electrodes were 
evaporated thermally on top of the device. In order to prevent the 
perovskite film from oxidation, the devices were sealed by a 25 µm thick 
hot-melting polymer (Surlyn®) and a microscope coverslip. To provide a 
complete sealing, the edges of the microscope coverslip were treated with 
epoxy resin. The devices were stored for about 12 h before measuring 
under inert conditions to allow complete hardening of the epoxy resin. 
Characterization methods: X-ray diffraction measurements on films and 
the powder sample of the precipitate were performed using a Bruker D8 
Discover X-ray diffractometer operating at 40 kV and 30 mA, employing 
Ni-filtered Cu Kα radiation (λ = 1.5406 Å) and a position-sensitive detector 
(LynxEye) in reflection mode. All other powder x-ray pattern were obtained 
in transmission mode by a STOE Stadi MP diffractometer with a Cu Kα1 
radiation source (λ = 1.54060 Å) operating at 40 kV and 40 mA. The 
diffractometer was equipped with a DECTRIS MYTHEN 1K solid-state strip 
detector. All samples were exposed to ambient conditions during the 
measurement. Scanning electron microscopy (SEM) cross-section images 
were acquired on a JEOL JSM-6500F microscope. The sample was fixed 
in a self-made sample holder. SEM top-view images were taken with a Carl 
Zeiss Ultra Plus scanning electron microscope. The sample was fixed by 
a sticky carbon pad. All SEM samples were exposed to ambient conditions 
not longer than one minute during the transfer procedure into the SEM. 
For the optical characterization, precursor solutions were prepared 
similarly as used for the devices. 100 µL of the solution was spun using 
the same conditions as utilized for solar cells onto a glass slide. 
Subsequently, the film was sealed by a glass coverslip and epoxy resin to 
avoid oxidation. Steady-state absorption spectra were acquired with a 
Lambda 1050 UV-Vis spectrophotometer (Perkin Elmer) using an 
integration sphere. Steady state and time-resolved PL measurements 
were performed with a Fluotime 300 Spectrofluorometer (Picoquant 
GmbH). The excitation wavelength was fixed at 510 nm. The emission for 
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time-resolved measurements was monitored at the maximum intensity of 
the steady state photo-emission. J-V curves were recorded with a Keithley 
2400 source meter under simulated AM 1.5 sunlight, calibrated to 100 mW 
cm−² with a Fraunhofer ISE certified silicon cell. The active area of the solar 
cells was defined with a square metal aperture mask of 0.0831 cm2. 
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